News for Ceapro Inc. (CRPOF)

TORONTO, ONTARIO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty...

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX…

Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) —

TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) —

Audited Consolidated Financial Statements of Ceapro Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 A-2 ...

Aeterna Zentaris Reports First Quarter 2024 Financial Results

Company ended the quarter with $29.5 million in cash DETECT-trial recruitment completed; Company continues to expect the completion of the trial in the second…

MATERIAL CHANGE REPORT 1. Name and Address of Company Aeterna Zentaris Inc. c/o...

The market size for beta-glucan industry is expected to be worth $542 million in 2024, growing at an 8.1% CAGR to $800 million by 2029....

/PRNewswire/ -- The

/PRNewswire/ -- The

/PRNewswire/ -- The "The Global Market for Cellulose Microfibers (Microfibrillated Cellulose) and Cellulose Nanofibers (Nanofibrillated Cellulose) 2023-2033"...

/PRNewswire/ -- The